J&J: Potential HIV vaccine falls short in mid-stage study
A potential HIV vaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the drugmaker said Tuesday.
News Headlines: J&J: Potential HIV vaccine falls short in mid-stage study
J&J: Potential HIV vaccine falls short in mid-stage study
A potential HIV vaccine being developed by Johnson & Johnson did not provide protection against the virus in a mid-stage study, the drugmaker said Tuesday.
Posts
No comments:
Post a Comment
Do not add any spam link on Comment Section.